Pure Global
NCT06294457

Effectiveness of Non-invasive Neuromodulation for Intestinal Transit in Healthy Subjects

Effectiveness of Non-invasive Neuromodulation Treatment (NESA) for the Management of Constipation Without Diagnosed Pathology in Students of the European University of Madrid (Spain)
Universidad Europea de Madrid·ClinicalTrials.gov·device·Device trialNot yet recruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Constipation
Drug/Device/Intervention
Non-Invasive Neuromodulation NESA
Study type
Interventional
Intervention type
device
Sponsor & location
Primary sponsor
Universidad Europea de Madrid
Timeline & enrollment
Phase
N/A
Start date
Mar 01, 2024
End date
Jun 01, 2024
Enrollment
40 participants
Primary outcome

Quality of life by constipation (CVE-20)

Summary

Objectives
 
 Main objective:
 
 Assess the effectiveness of non-invasive neuromodulation treatment (NESA) for the management
 of constipation in patients without diagnosed pathology in Spain
 
 Secondary objectives:
 
 Evaluate the improvement in sleep quality Analyze the improvement in blood pressure quality
 Measure the improvement in cortisol quality Determine if there is an improvement in heart
 rate

ICD-10 classifications
ConstipationIrritable bowel syndrome with predominant constipation [IBS-C]Other laxativesPoisoning: Other laxativesOther functional intestinal disorders
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06294457
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT06294457 through Pure Global AI's free database. This phase not specified trial is sponsored by Universidad Europea de Madrid and is currently Not yet recruiting. The study focuses on Constipation. Target enrollment is 40 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.